Skip to main content
Top
Published in: Archives of Osteoporosis 1-2/2011

Open Access 01-12-2011 | Original Article

Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta

Authors: Lena Lande Wekre, Erik F. Eriksen, Jan A. Falch

Published in: Archives of Osteoporosis | Issue 1-2/2011

Login to get access

Abstract

Summary

Still little is known about the manifestations of osteogenesis imperfecta (OI) in adults. We therefore initiated this study of bone mass, bone turnover and prevalence of fractures in a large cohort of adult patients. We found a surprising low prevalence (10%) of osteoporosis. These patients, however, expressed the most severe disease.

Purpose

To characterize bone mineral density, bone turnover, calcium metabolism and prevalence of fractures in a large cohort of adults with osteogenesis imperfecta.

Methods

One hundred fifty-four patients with adult OI participated and 90 (age range 25–83) provided dual X-ray absorptiometry (DXA) measurements. According to Sillence classification criteria, 68 persons were classified as OI type I, 9 as type III, 11 type IV and 2 were unclassified. Fracture numbers were based on self-reporting. Biochemical markers of bone turnover were measured and bone mineral density (BMD) of the spine, femoral neck and total body were determined by DXA.

Results

Only 10% of adults with OI exhibited osteoporotic T scores (T ≤ −2.5) but compared to patients with normal T scores this subgroup had a threefold higher fracture risk (22 vs. 69). s-PTH, s-Ca and 25[OH] vitamin D were all normal. Bone markers did not display major deviations from normal, but patients with OI type III displayed higher resorption marker levels than type I and IV. Multivariate regression analysis showed that only gender and total body BMD were significant determinants of fracture susceptibility, and the differences for total body BMC, BMD and Z scores were significant between the OI subtypes.

Conclusions

In adult OI, DXA measurements only identified few patients as osteoporotic. These patients, however, exhibited a much higher fracture propensity. Due to deformities, low body height and pre-existing fractures, DXA assessment is complicated in this disease, and further studies are needed to work out how to minimize the impact of these confounders.
Literature
1.
go back to reference Rowe WD, Shapiro RY (1990) Osteogenesis imperfecta. In: Avioli L, Krane S (eds) Metabolic bone disease and clinical related disorders, 2nd edn. WB Saunders, USA, Philadelphia, pp 659–701 Rowe WD, Shapiro RY (1990) Osteogenesis imperfecta. In: Avioli L, Krane S (eds) Metabolic bone disease and clinical related disorders, 2nd edn. WB Saunders, USA, Philadelphia, pp 659–701
2.
go back to reference Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 15:101–116CrossRef Sillence DO, Senn A, Danks DM (1979) Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 15:101–116CrossRef
3.
go back to reference Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P et al (2009) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650–1658CrossRef Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P et al (2009) Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res 15:1650–1658CrossRef
4.
go back to reference Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38PubMedCrossRef Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R (2002) Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res 17:30–38PubMedCrossRef
5.
go back to reference Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH (2002) Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 31:12–18PubMedCrossRef Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L, Roughley PJ, Glorieux FH (2002) Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 31:12–18PubMedCrossRef
6.
go back to reference Roughly PJ, Rauch F, Glorieux FH (2003) Osteogenesis imperfecta—clinical and molecular diversity. Eur Cell Mater 5:41–47 Roughly PJ, Rauch F, Glorieux FH (2003) Osteogenesis imperfecta—clinical and molecular diversity. Eur Cell Mater 5:41–47
7.
go back to reference Viguet-Carrin S, Garnero P, Demas PD (2006) The role of collagen in bone strength. Osteoporos Int 17:319–36PubMedCrossRef Viguet-Carrin S, Garnero P, Demas PD (2006) The role of collagen in bone strength. Osteoporos Int 17:319–36PubMedCrossRef
8.
go back to reference Paterson C, McAllon S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Eng J M 310:1694–1696CrossRef Paterson C, McAllon S, Stellman JL (1984) Osteogenesis imperfecta after the menopause. N Eng J M 310:1694–1696CrossRef
9.
go back to reference Primorac D, Rowe DW, Mottes M, Barišić I, Antičević D et al (2001) Osteogenesis imperfecta at the beginning of bone and joint decade. CMJ 42:393–415PubMed Primorac D, Rowe DW, Mottes M, Barišić I, Antičević D et al (2001) Osteogenesis imperfecta at the beginning of bone and joint decade. CMJ 42:393–415PubMed
10.
go back to reference Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tatơ L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126–130PubMedCrossRef Adami S, Gatti D, Colapietro F, Fracassi E, Braga V, Rossini M, Tatơ L (2003) Intravenous neridronate in adults with osteogenesis imperfecta. J Bone Miner Res 18:126–130PubMedCrossRef
11.
go back to reference Whyte MP (1999) Osteogenesis imperfecta. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott-Williams and Wilkins, Philadelphia, pp 386–389 Whyte MP (1999) Osteogenesis imperfecta. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th edn. Lippincott-Williams and Wilkins, Philadelphia, pp 386–389
12.
go back to reference Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH (2003) Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986–992PubMedCrossRef Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH (2003) Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 88:986–992PubMedCrossRef
13.
go back to reference Meunier PJ (1999) Serum 25-hydroxy-vitamin D is often low, indicating vitamin D deficiency secondary to lack of exposure to sunlight, Abstractbook, 7th International Conference on Osteogenesis Imperfecta, Montreal, 1999 Meunier PJ (1999) Serum 25-hydroxy-vitamin D is often low, indicating vitamin D deficiency secondary to lack of exposure to sunlight, Abstractbook, 7th International Conference on Osteogenesis Imperfecta, Montreal, 1999
14.
go back to reference Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers C (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Eng J Med 339:947–952CrossRef Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers C (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Eng J Med 339:947–952CrossRef
15.
go back to reference Åstrøm E, Söderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356–364PubMedCrossRef Åstrøm E, Söderhall S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356–364PubMedCrossRef
16.
go back to reference Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293–1299PubMed Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293–1299PubMed
17.
go back to reference Gatti D, Colapietro F, Fracassi E, Sartori E, Antoniazzi F, Braga V, Rossini M, Adami S (2003) The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. J Clin Densitom 6:173–177PubMedCrossRef Gatti D, Colapietro F, Fracassi E, Sartori E, Antoniazzi F, Braga V, Rossini M, Adami S (2003) The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. J Clin Densitom 6:173–177PubMedCrossRef
18.
go back to reference Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013–1016PubMedCrossRef Braga V, Gatti D, Rossini M, Colapietro F, Battaglia E, Viapiana O, Adami S (2004) Bone turnover markers in patients with osteogenesis imperfecta. Bone 34:1013–1016PubMedCrossRef
19.
go back to reference Cepollaro C, Gonelli S, Pondrelli C, Montagnani A, Martini S, Bruni D, Gennari C (1999) Osteogenesis imperfecta: bone turnover, bone density and ultrasound parameters. Cacif Tissue Int 65:129–132CrossRef Cepollaro C, Gonelli S, Pondrelli C, Montagnani A, Martini S, Bruni D, Gennari C (1999) Osteogenesis imperfecta: bone turnover, bone density and ultrasound parameters. Cacif Tissue Int 65:129–132CrossRef
20.
go back to reference Lund AM, Hansen M, Kollerup G, Juul A, Teisner B, Skovby F (1998) Collagen-derived markers of bone metabolism in osteogenesis imperfecta. Acta Paediatr 87:1131–1137PubMedCrossRef Lund AM, Hansen M, Kollerup G, Juul A, Teisner B, Skovby F (1998) Collagen-derived markers of bone metabolism in osteogenesis imperfecta. Acta Paediatr 87:1131–1137PubMedCrossRef
22.
go back to reference Brenner RE, Vetter U, Bollen AM, Morike M, Eyre DR (1994) Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993–997PubMedCrossRef Brenner RE, Vetter U, Bollen AM, Morike M, Eyre DR (1994) Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta. J Bone Miner Res 9:993–997PubMedCrossRef
23.
go back to reference Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histometry in children with osteogenesis imperfecta. Bone 26:581–589PubMedCrossRef Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histometry in children with osteogenesis imperfecta. Bone 26:581–589PubMedCrossRef
24.
go back to reference Chines A, Petersen DJ, Schrank FW, Whyte MP (1991) Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr 119:51–57PubMedCrossRef Chines A, Petersen DJ, Schrank FW, Whyte MP (1991) Hypercalciuria in children severely affected with osteogenesis imperfecta. J Pediatr 119:51–57PubMedCrossRef
25.
go back to reference WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva, Switzerland) Prevention and management of osteoporosis: report of a WHO scientific group. (WHO Technical Report Series No 921) WHO Scientific Group on the Prevention and Management of Osteoporosis (2000: Geneva, Switzerland) Prevention and management of osteoporosis: report of a WHO scientific group. (WHO Technical Report Series No 921)
26.
go back to reference Wekre LL, Froslie KF, Haugen L, Falch JA (2010) A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil 32:579–587PubMedCrossRef Wekre LL, Froslie KF, Haugen L, Falch JA (2010) A population-based study of demographical variables and ability to perform activities of daily living in adults with osteogenesis imperfecta. Disabil Rehabil 32:579–587PubMedCrossRef
27.
go back to reference Teegarden D, Proulx WR, Martin BR, Zhao J, McCabe GP, Lyle RM, Peacock M, Slemenda C, Johnston CC, Weaver CM (1995) Peak bone mass in young women. J Bone Miner Res 10:711–715PubMedCrossRef Teegarden D, Proulx WR, Martin BR, Zhao J, McCabe GP, Lyle RM, Peacock M, Slemenda C, Johnston CC, Weaver CM (1995) Peak bone mass in young women. J Bone Miner Res 10:711–715PubMedCrossRef
28.
go back to reference Marini JC (1988) Osteogenesis imperfecta: comprehensive management. Adv Pediatr 35:391–426PubMed Marini JC (1988) Osteogenesis imperfecta: comprehensive management. Adv Pediatr 35:391–426PubMed
29.
go back to reference Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG, Tell GS (2004) Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int 15:525–534PubMedCrossRef Gjesdal CG, Aanderud SJ, Haga HJ, Brun JG, Tell GS (2004) Femoral and whole-body bone mineral density in middle-aged and older Norwegian men and women: suitability of the reference values. Osteoporos Int 15:525–534PubMedCrossRef
31.
go back to reference Huang RP, Ambrose CG, Sullivan E, Haynes RJ (2006) Functional significance of bone density measurements in children with osteogenesis imperfecta. JBJS Am 88:1324–1330CrossRef Huang RP, Ambrose CG, Sullivan E, Haynes RJ (2006) Functional significance of bone density measurements in children with osteogenesis imperfecta. JBJS Am 88:1324–1330CrossRef
32.
go back to reference Paterson CR, Mole PA (1994) Bone density in osteogenesis imperfecta may well be normal. Postgrad Med J 70:104–107PubMedCrossRef Paterson CR, Mole PA (1994) Bone density in osteogenesis imperfecta may well be normal. Postgrad Med J 70:104–107PubMedCrossRef
Metadata
Title
Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta
Authors
Lena Lande Wekre
Erik F. Eriksen
Jan A. Falch
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Archives of Osteoporosis / Issue 1-2/2011
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-011-0054-z

Other articles of this Issue 1-2/2011

Archives of Osteoporosis 1-2/2011 Go to the issue